Digital Content 
NEWS #PharmaBuzz
10 Aug 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213427
17 Nov 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213447
15 Nov 2021
// EXPRESS PHARMA
https://www.expresspharma.in/zydus-cadila-receives-tentative-approval-from-us-fda-for-eluxadoline-tablets/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-viberzi-206940-eluxadoline-tablets-75-mg-and-100-mg-1564811438.pdf
10 Jul 2017
// PR NEWSWIRE
http://www.prnewswire.com/news-releases/allergan-reports-new-data-reinforcing-the-effectiveness-of-viberzi-eluxadoline-to-treat-the-symptoms-associated-with-irritable-bowel-syndrome-with-diarrhea-ibs-d-abdominal-pain-and-diarrhea-300485192.html
16 Mar 2017
// Zachary Brennan RAPS
http://raps.org/Regulatory-Focus/News/2017/03/15/27114/FDA-Warns-of-Increased-Risk-of-Serious-Pancreatitis-with-Allergan%E2%80%99s-Viberzi/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
Share 